86 related articles for article (PubMed ID: 2111867)
1. The prostacyclin analogue taprostene and recombinant human superoxide dismutase increase the permanent survival rate of endotoxemic rats.
Schneider J; Matthiesen T
Life Sci; 1990; 46(20):1421-6. PubMed ID: 2111867
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats.
Schneider J; Friderichs E; Heintze K; Flohé L
Circ Shock; 1990 Feb; 30(2):97-106. PubMed ID: 2178795
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of the prostacyclin analogue taprostene on cardiovascular, pulmonary and renal disturbances in endotoxin-shocked rabbits.
Schneider J
Eicosanoids; 1991; 4(2):99-105. PubMed ID: 1910868
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and curative effects of recombinant human superoxide dismutase in lethal rat endotoxemia.
Schneider J
Arzneimittelforschung; 1988 Sep; 38(9):1381-6. PubMed ID: 3066366
[TBL] [Abstract][Full Text] [Related]
5. Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion.
Ma XL; Johnson G; Lefer AM
J Am Coll Cardiol; 1992 Jan; 19(1):197-204. PubMed ID: 1729334
[TBL] [Abstract][Full Text] [Related]
6. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
7. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep.
Koyama S; Kobayashi T; Kubo K; Sekiguchi M; Ueda G
Am Rev Respir Dis; 1992 Jun; 145(6):1404-9. PubMed ID: 1317693
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
VanAntwerp DR; Hedley LR; Spires DA; Strosberg AM; Johnson G; Lefer AM
Eicosanoids; 1991; 4(1):15-20. PubMed ID: 2059456
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
Michel G; Seipp U
Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
[TBL] [Abstract][Full Text] [Related]
10. Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial.
Virgolini I; Fitscha P; O'Grady J; Barth H; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):31-5. PubMed ID: 2514430
[TBL] [Abstract][Full Text] [Related]
11. Additional myocardial salvage by coadministration of the epoprostenol analog taprostene to recombinant single-chain urokinase-type plasminogen activator in a canine coronary thrombosis model.
Groves R; Schneider J; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1989 Apr; 39(4):534-8. PubMed ID: 2665759
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical aspects of endotoxicosis in rat: lipid peroxide formation and the effect of free radical scavengers].
Sekigawa T
Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):1-19. PubMed ID: 6397231
[No Abstract] [Full Text] [Related]
13. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats.
Korbut R; Gryglewski RJ
J Physiol Pharmacol; 1996 Dec; 47(4):591-9. PubMed ID: 9116326
[TBL] [Abstract][Full Text] [Related]
14. Changes in hepatic lipoperoxide concentration in endotoxemic rats.
Ogawa R; Morita T; Kunimoto F; Fujita T
Circ Shock; 1982; 9(4):369-74. PubMed ID: 6749322
[TBL] [Abstract][Full Text] [Related]
15. Effects of taprostene on neutrophil-endothelial interactions in isolated coronary arteries.
Lefer AM; Murohara T; Buerke M
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):623-31. PubMed ID: 7746023
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lipid peroxidation improves survival rate of endotoxemic rats.
Kunimoto F; Morita T; Ogawa R; Fujita T
Circ Shock; 1987; 21(1):15-22. PubMed ID: 3028669
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
Wilson SM; Sheddan NA; Newton R; Giembycz MA
Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
[TBL] [Abstract][Full Text] [Related]
18. The effect of taprostene in patients with acute myocardial infarction treated with thrombolytic therapy: results of the START study. Saruplase Taprostene Acute Reocclusion Trial.
Bär FW; Meyer J; Michels R; Uebis R; Lange S; Barth H; Groves R; Vermeer F
Eur Heart J; 1993 Aug; 14(8):1118-26. PubMed ID: 8404943
[TBL] [Abstract][Full Text] [Related]
19. Effect of TRK-100, a prostacyclin analogue, on endotoxin-induced enhancement of blood coagulation in rats.
Sakai A; Hori T; Okuda T; Matsubara T; Saitoh K; Yajima M; Nishio S
Jpn J Pharmacol; 1989 Nov; 51(3):450-4. PubMed ID: 2516170
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat.
Bianca Rd; Wayman NS; McDonald MC; Pinto A; Shape MA; Chatterjee PK; Thiemermann C
Med Sci Monit; 2002 Jan; 8(1):BR1-7. PubMed ID: 11796957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
